Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
Px-102
print preview
bookmark
share with colleague
General Information
Company
Phenex Pharmaceuticals AG
Description
Non-steroidal farnesoid X receptor (FXR) agonist
Molecular Target
Farnesoid X receptor (FXR) (NR1H4)
Mechanism of Action
Latest Stage of Development
Phase I
Indication
Non-alcoholic steatohepatitis (NASH)
Partner
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy